Literature DB >> 10860926

Two-stage glucocorticoid induction of CYP3A23 through both the glucocorticoid and pregnane X receptors.

J M Huss1, C B Kasper.   

Abstract

Glucocorticoid inducibility of the CYP3A23 gene is conferred by a multisite unit comprising binding sites for several members of the nuclear receptor superfamily of transcription factors, including the chicken ovalbumin upstream promoter-transcription factor COUP-TF, pregnane X receptor (PXR), and hepatocyte nuclear factor 4 (HNF-4). The presence of three binding sites, each of which interacts with more than one factor, contributes to the complexity of the CYP3A23 glucocorticoid-responsive region. Despite the glucocorticoid sensitivity of this gene, direct binding of ligand-activated glucocorticoid receptor (GR) to the CYP3A23 dexamethasone-responsive region (DexRE) is not required for induction. This study demonstrates that DexRE-2 is the key element within the CYP3A23 proximal promoter, conferring ligand sensitivity via its interaction with the PXR/RXRalpha heterodimer. The DexRE-1 and HNF-4 sites are not ligand-responsive, but are essential accessory elements required for full promoter inducibility. In addition to ligand-mediated activation of PXR, the overall induction response involves a GR-mediated stimulation of PXR and RXRalpha expression. Hence, the induction pathway can be divided into two stages. In stage one, maximal induction requires a GR-dependent increase in PXR and RXRalpha expression, and stage two is characterized by direct transcriptional activation of CYP3A23, which is dependent on ligand-activated PXR as well as accessory factors bound at the DexRE-1 and HNF-4 sites. Because multiple proteins bind at each element within the glucocorticoid-responsive region, factors not contributing to ligand responsiveness, such as chicken ovalbumin upstream promoter-transcription factor, may modulate the response through competitive interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860926     DOI: 10.1124/mol.58.1.48

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23.

Authors:  Deshi Shi; Dongfang Yang; Bingfang Yan
Journal:  Biochem Pharmacol       Date:  2010-07-01       Impact factor: 5.858

2.  Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice.

Authors:  Anna K Kopec; Michelle L D'Souza; Bryan D Mets; Lyle D Burgoon; Sarah E Reese; Kellie J Archer; Dave Potter; Colleen Tashiro; Bonnie Sharratt; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-07       Impact factor: 4.219

Review 3.  CYP induction-mediated drug interactions: in vitro assessment and clinical implications.

Authors:  Jiunn H Lin
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 4.  Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

Authors:  Hongbing Wang; Edward L LeCluyse
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression.

Authors:  Xingguo Cheng; David Buckley; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

Review 6.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

7.  Induction of human UGT1A1 by a complex of dexamethasone-GR dependent on proximal site and independent of PBREM.

Authors:  Takuya Kuno; Hiroshi Togawa; Takaharu Mizutani
Journal:  Mol Biol Rep       Date:  2007-05-26       Impact factor: 2.316

Review 8.  Pharmacokinetic drug interactions in liver disease: An update.

Authors:  Pietro Palatini; Sara De Martin
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

9.  ChIPing the cistrome of PXR in mouse liver.

Authors:  Julia Yue Cui; Sumedha S Gunewardena; Cheryl E Rockwell; Curtis D Klaassen
Journal:  Nucleic Acids Res       Date:  2010-08-06       Impact factor: 16.971

10.  Regulation of Fgf15 expression in the intestine by glucocorticoid receptor.

Authors:  Kunzhi Jia; Danping Zhang; Qi Jia; Qing-Yu Zhang
Journal:  Mol Med Rep       Date:  2019-01-30       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.